Portola Pharma (PTLA), CMC ICOS Biologics Enter Commercial Supply Agreement
Tweet Send to a Friend
On July 1, 2014, Portola Pharma (Nasdaq: PTLA) entered into a Commercial Supply (Manufacturing Services) Agreement (the “Agreement”) with CMC ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE